Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences
Cancer Communications · 01.01.2026 · 46
DOI: 10.34133/cancomm.0035 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cancer Communications, online erschienen am 17.06.2026. Verfasst von Damien Bruyat und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
- Aix-Marseille Université, INSERM U1068, CNRS UMR7258, Centre de Recherche en Cancérologie de Marseille (CRCM), Immunity and Cancer Team, Marseille, France.
- Department of Medical Oncology, Institut Curie, Paris, France.
- Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
- Department of Medical Oncology, Centre Oscar-Lambret, Lille, France.
- ULR 2694-METRICS (Évaluation des technologies de santé et des pratiques médicales), Centre Hospitalo-Universitaire de Lille, University of Lille, Lille, France.
ORCID-Profile: Damien Bruyat
Zitieren
APA
Bruyat, D., Girard, N., Heudel, P., Penel, N., Le Deley, M. C., Diallo, I., Boher, J. M., Zemmour, C., Chanez, B., Madroszyk, A., Gravis, G., Billon, E., Lisberg, A., Collineau, B., Beaufils, M., Gonçalves, A., Tejeda, M., Chrétien, A. S., & Rochigneux, P. (2026). Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0035
Vancouver
Bruyat D, Girard N, Heudel P, Penel N, Le Deley MC, Diallo I, et al. Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences. Cancer Communications. 2026;46. doi:10.34133/cancomm.0035
BibTeX
@article{Bruyat2026,
author = {Bruyat, Damien and Girard, Nicolas and Heudel, Pierre and Penel, Nicolas and Le Deley, Marie-Cécile and Diallo, Issaga and Boher, Jean-Marie and Zemmour, Christophe and Chanez, Brice and Madroszyk, Anne and Gravis, Gwenaelle and Billon, Emilien and Lisberg, Aaron and Collineau, Bérénice and Beaufils, Mathilde and Gonçalves, Anthony and Tejeda, Manuel and Chrétien, Anne-Sophie and Rochigneux, Philippe},
title = {Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences},
journal = {Cancer Communications},
year = {2026},
volume = {46},
doi = {10.34133/cancomm.0035}
}
EUVIMED